The Fondation Maladies Rares and Novo Nordisk are pleased to announce the launch of the first research grant dedicated to improving the quality of life of sickle cell disease patients.
🏆 This €30,000 grant will be awarded to a research project in the human and social sciences, the spin-offs of which will offer concrete ways of improving the day-to-day lives of patients.
Particular attention will be paid to projects whose results could be transposed to other hemolytic anemias.
📆 Applications before September 19, 2023 at 5pm.
We hope that many of you will respond to this call for projects!